Display options
Share it on

Blood Cancer J. 2014 Jan 24;4:e179. doi: 10.1038/bcj.2013.76.

EVI1 expression in childhood acute lymphoblastic leukaemia is not restricted to MLL and BCR/ABL rearrangements and is influenced by age.

Blood cancer journal

A Stevens, D Hanson, C de Leonibus, A Whatmore, R Donn, D J White, J Liu, M M van den Heuvel-Eibrink, V Saha, P E Clayton, S Meyer

Affiliations

  1. 1] Department of Paediatric Endocrinology, Royal Manchester Children's Hospital, Manchester, UK [2] Manchester Academic Health Science Centre, University of Manchester, Royal Manchester Children's Hospital, Manchester, UK.
  2. 1] Manchester Academic Health Science Centre, University of Manchester, Royal Manchester Children's Hospital, Manchester, UK [2] The Centre for Musculoskeletal Research, Manchester, UK.
  3. 1] Manchester Academic Health Science Centre, University of Manchester, Royal Manchester Children's Hospital, Manchester, UK [2] Stem Cell and Leukaemia Proteomics Laboratory, Manchester, UK.
  4. 1] Children's Cancer Group, Manchester, UK [2] Institute for Cancer Sciences, University of Manchester, Manchester, UK.
  5. Department of Pediatric Hematology and Oncology, Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands.
  6. 1] Manchester Academic Health Science Centre, University of Manchester, Royal Manchester Children's Hospital, Manchester, UK [2] Children's Cancer Group, Manchester, UK [3] Institute for Cancer Sciences, University of Manchester, Manchester, UK [4] Tata Translational Cancer Research Centre, Kolkata, India.
  7. 1] Manchester Academic Health Science Centre, University of Manchester, Royal Manchester Children's Hospital, Manchester, UK [2] Stem Cell and Leukaemia Proteomics Laboratory, Manchester, UK [3] Institute for Cancer Sciences, University of Manchester, Manchester, UK [4] Department of Paediatric Oncology, Royal Manchester Children's Hospital, Manchester, UK [5] Young Oncology Unit, The Christie NHS foundation Trust, Manchester, UK.

PMID: 24464103 PMCID: PMC3913945 DOI: 10.1038/bcj.2013.76

[No abstract available.]

References

  1. Blood. 2011 Nov 10;118(19):5218-26 - PubMed
  2. Leukemia. 2013 Jan;27(1):56-65 - PubMed
  3. Leukemia. 2013 Apr;27(4):852-60 - PubMed
  4. J Clin Invest. 2009 Jul;119(7):1964-73 - PubMed
  5. Cell Stem Cell. 2008 Aug 7;3(2):207-20 - PubMed
  6. Oncogene. 2006 Jun 15;25(25):3565-75 - PubMed
  7. Blood. 2012 Jun 14;119(24):5838-49 - PubMed
  8. Proc Natl Acad Sci U S A. 2013 Jul 30;110(31):E2885-94 - PubMed
  9. Br J Haematol. 2013 Sep;162(5):670-7 - PubMed
  10. Leukemia. 2010 May;24(5):942-9 - PubMed
  11. BMC Genomics. 2013 Aug 13;14:547 - PubMed
  12. Blood. 2011 Jun 9;117(23):6267-76 - PubMed
  13. Br J Haematol. 2012 May;157(4):446-56 - PubMed
  14. Lancet Oncol. 2009 Feb;10(2):125-34 - PubMed
  15. Proc Natl Acad Sci U S A. 2006 May 23;103(21):8167-72 - PubMed
  16. Blood. 2008 Apr 15;111(8):4329-37 - PubMed

Publication Types

Grant support